PH19845A - Calciferol derivatives - Google Patents

Calciferol derivatives

Info

Publication number
PH19845A
PH19845A PH31827A PH31827A PH19845A PH 19845 A PH19845 A PH 19845A PH 31827 A PH31827 A PH 31827A PH 31827 A PH31827 A PH 31827A PH 19845 A PH19845 A PH 19845A
Authority
PH
Philippines
Prior art keywords
calciferol
derivatives
calciferol derivatives
Prior art date
Application number
PH31827A
Other languages
English (en)
Inventor
Enrico Guiseppe Baggiolini
Andrew David Batcho
Gary Arhtur Truitt
Milan Radoje Uskokovic
Peter Michael Wovkulich
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PH19845A publication Critical patent/PH19845A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C35/00—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring
    • C07C35/22—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system
    • C07C35/23—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings
    • C07C35/32—Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a ring other than a six-membered aromatic ring polycyclic, at least one hydroxy group bound to a condensed ring system with hydroxy on a condensed ring system having two rings the condensed ring system being a (4.3.0) system, e.g. indenols
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/20—Free hydroxyl or mercaptan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/26—Radicals substituted by doubly bound oxygen or sulfur atoms or by two such atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PH31827A 1984-02-08 1985-02-07 Calciferol derivatives PH19845A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57816084A 1984-02-08 1984-02-08
US68212584A 1984-12-17 1984-12-17

Publications (1)

Publication Number Publication Date
PH19845A true PH19845A (en) 1986-07-22

Family

ID=27077449

Family Applications (1)

Application Number Title Priority Date Filing Date
PH31827A PH19845A (en) 1984-02-08 1985-02-07 Calciferol derivatives

Country Status (10)

Country Link
EP (1) EP0154185B1 (da)
JP (1) JPH0735365B2 (da)
AU (1) AU575373B2 (da)
CA (1) CA1311501C (da)
DE (1) DE3565401D1 (da)
DK (1) DK157244C (da)
IE (1) IE57917B1 (da)
IL (1) IL74264A (da)
NZ (1) NZ211071A (da)
PH (1) PH19845A (da)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL77668A (en) * 1986-01-21 1989-03-31 Teva Pharma Production of cholecalciferol derivatives and novel intermediates used therefor
GB2229921B (en) * 1989-04-05 1992-12-16 Chugai Pharmaceutical Co Ltd Treatment for hyperparathyroidism with use of vitamin d derivatives
CA2062520C (en) * 1991-03-11 1998-08-11 Hector F. Deluca Synthesis of 1-alpha-hydroxy-secosterol compounds
AU650751B2 (en) * 1991-05-28 1994-06-30 Wisconsin Alumni Research Foundation Novel synthesis of 19-nor vitamin D compounds
US5300705A (en) * 1993-03-18 1994-04-05 Hoffmann-La Roche Inc. Process for the preparation of 1α,25,26-trihydroxy-22-ene-cholecalciferol
JP4752110B2 (ja) * 2000-12-25 2011-08-17 住友化学株式会社 トリフルオロプロペニル化合物の製造法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069321A (en) * 1975-10-14 1978-01-17 Merck & Co., Inc. Blocked cholecalciferol and dihydrotachysterol 3 derivatives
CA1206882A (en) * 1982-02-12 1986-07-02 Hoffmann-La Roche Limited Use of cholecalciferol derivatives
EP0086350A3 (de) * 1982-02-12 1984-11-28 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Verfahren zur Herstellung von Cholesterinderivaten
JPS58210017A (ja) * 1982-05-31 1983-12-07 Kureha Chem Ind Co Ltd 抗腫瘍剤
ATE90564T1 (de) * 1982-06-30 1993-07-15 Gen Hospital Corp Vitamin d glycoside.
DE3471928D1 (en) * 1983-01-28 1988-07-14 Hoffmann La Roche Process for the preparation of cholecalciferol derivatives

Also Published As

Publication number Publication date
EP0154185B1 (en) 1988-10-05
IE850298L (en) 1985-08-08
DE3565401D1 (de) 1988-11-10
IL74264A0 (en) 1985-05-31
JPS60248664A (ja) 1985-12-09
DK53785D0 (da) 1985-02-06
DK157244C (da) 1990-04-23
CA1311501C (en) 1992-12-15
AU575373B2 (en) 1988-07-28
EP0154185A1 (en) 1985-09-11
DK53785A (da) 1985-08-09
IL74264A (en) 1988-08-31
DK157244B (da) 1989-11-27
NZ211071A (en) 1988-04-29
AU3846985A (en) 1985-08-15
IE57917B1 (en) 1993-05-19
JPH0735365B2 (ja) 1995-04-19

Similar Documents

Publication Publication Date Title
IL90300A0 (en) Substituted aminobenzonitriles
EP0150447A3 (en) Substituted dihydrobenzopyran-2-carboxylates
AU575373B2 (en) Calciferol derivatives
ZA854165B (en) Substituted phenylsuphonylureas
ZA856582B (en) Substituted carbonylphenylsulphonylguanidines
GB8427227D0 (en) Anti-nutation means
ZA856592B (en) Substituted arylsulphonylguanidines
GB2192884B (en) Substituted ethanediimidamides
CS32184A1 (en) Zarizeni k upinani osazenych hridelu
ZA85907B (en) Calciferol derivatives
BG37869A1 (en) Antifungi means
BG38501A1 (en) Antiphytoviral means
BG37094A1 (en) Antigrippe means
GB8401007D0 (en) Spray-inhibiting means
ZA856087B (en) Substituted 7-oxomitosanes
CS1038084A1 (en) Zarizeni k ohrivani spalovaciho vzduchu horaku
CS130584A1 (en) Zarizeni k uzavirani privodu plynu
CS100584A1 (en) Pojivo k vyrobe laminovanych materialu
CS241584A1 (en) Zarizeni k propichovani nezvulkanizovanych plastu
CS209684A1 (en) Zarizeni k cirkulaci chladiva
CS255284A1 (en) Smesna antidetonacni prisada k nizkoolovnatym pripadne bezolovnatym autobenzinum
CS34384A1 (en) Pristroj k demonstraci konvekcnich proudu
CS363984A1 (en) Zarizeni k fluidicko hydraulicke regulaci hladiny kapalin
CS451884A1 (en) Zarizeni k aplikaci agrochemikalii prostrednictvim zavlah
CS433084A1 (en) Zarizeni k opticke indikaci malych mechanickych posunuti